# A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers

> **NCT00387413** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 40 (actual)

## Conditions studied

- Hyperalgesia

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** GSK189254
- **DRUG:** GSK189254 Placebo
- **DRUG:** Duloxetine Placebo

## Key facts

- **NCT ID:** NCT00387413
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-02
- **Primary completion:** 2007-05-31
- **Final completion:** 2007-05-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387413, "A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00387413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*